DERMAPHARM HOLDING SE (DMP.DE) Stock Fundamental Analysis
Europe - Frankfurt Stock Exchange - FRA:DMP - DE000A2GS5D8 - Common Stock
37 EUR
0 (0%)
Overall DMP gets a fundamental rating of 5 out of 10. We evaluated DMP against 54 industry peers in the Pharmaceuticals industry. DMP has only an average score on both its financial health and profitability. DMP is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year DMP was profitable.
In the past year DMP had a positive cash flow from operations.
Each year in the past 5 years DMP has been profitable.
DMP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 5.48%, DMP perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
DMP has a Return On Equity of 17.87%. This is in the better half of the industry: DMP outperforms 61.11% of its industry peers.
The Return On Invested Capital of DMP (7.26%) is comparable to the rest of the industry.
Measured over the past 3 years, the Average Return On Invested Capital for DMP is below the industry average of 13.89%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROIC | 7.26% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
1.3 Margins
DMP has a Profit Margin (10.00%) which is in line with its industry peers.
In the last couple of years the Profit Margin of DMP has declined.
DMP's Operating Margin of 18.70% is in line compared to the rest of the industry. DMP outperforms 50.00% of its industry peers.
In the last couple of years the Operating Margin of DMP has grown nicely.
Looking at the Gross Margin, with a value of 66.57%, DMP is in line with its industry, outperforming 42.59% of the companies in the same industry.
In the last couple of years the Gross Margin of DMP has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% |
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DMP is creating some value.
The number of shares outstanding for DMP remains at a similar level compared to 1 year ago.
Compared to 5 years ago, DMP has about the same amount of shares outstanding.
Compared to 1 year ago, DMP has a worse debt to assets ratio.
2.2 Solvency
DMP has an Altman-Z score of 2.23. This is not the best score and indicates that DMP is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.23, DMP perfoms like the industry average, outperforming 46.30% of the companies in the same industry.
The Debt to FCF ratio of DMP is 6.15, which is on the high side as it means it would take DMP, 6.15 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 6.15, DMP is in line with its industry, outperforming 44.44% of the companies in the same industry.
A Debt/Equity ratio of 1.44 is on the high side and indicates that DMP has dependencies on debt financing.
The Debt to Equity ratio of DMP (1.44) is worse than 74.07% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Altman-Z | 2.23 |
ROIC/WACC1.16
WACC6.26%
2.3 Liquidity
A Current Ratio of 2.20 indicates that DMP has no problem at all paying its short term obligations.
With a decent Current ratio value of 2.20, DMP is doing good in the industry, outperforming 74.07% of the companies in the same industry.
DMP has a Quick Ratio of 1.04. This is a normal value and indicates that DMP is financially healthy and should not expect problems in meeting its short term obligations.
DMP has a better Quick ratio (1.04) than 64.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.01% over the past year.
The Earnings Per Share has been growing by 8.07% on average over the past years. This is quite good.
DMP shows a small growth in Revenue. In the last year, the Revenue has grown by 0.11%.
DMP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.00% yearly.
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
3.2 Future
The Earnings Per Share is expected to grow by 14.68% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.09% on average over the next years.
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 17.21, which indicates a rather expensive current valuation of DMP.
DMP's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 26.76, DMP is valued a bit cheaper.
Based on the Price/Forward Earnings ratio of 14.48, the valuation of DMP can be described as correct.
Based on the Price/Forward Earnings ratio, DMP is valued a bit cheaper than the industry average as 64.81% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.96, DMP is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.21 | ||
| Fwd PE | 14.48 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, DMP is valued a bit cheaper than the industry average as 74.07% of the companies are valued more expensively.
DMP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. DMP is cheaper than 83.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.12 | ||
| EV/EBITDA | 9.42 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.37
PEG (5Y)2.13
EPS Next 2Y11.78%
EPS Next 3Y11.05%
5. Dividend
5.1 Amount
DMP has a Yearly Dividend Yield of 2.37%. Purely for dividend investing, there may be better candidates out there.
DMP's Dividend Yield is a higher than the industry average which is at 2.90.
Compared to an average S&P500 Dividend Yield of 2.31, DMP has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.37% |
5.2 History
The dividend of DMP has a limited annual growth rate of 2.71%.
Dividend Growth(5Y)2.71%
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
41.76% of the earnings are spent on dividend by DMP. This is a bit on the high side, but may be sustainable.
DMP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.76%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
FRA:DMP (12/12/2025, 10:57:42 AM)
37
0 (0%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners11.86%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.99B
Revenue(TTM)1.16B
Net Income(TTM)116.03M
Analysts78.18
Price Target42.84 (15.78%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.37% |
Yearly Dividend0.88
Dividend Growth(5Y)2.71%
DP41.76%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.94%
PT rev (3m)-0.94%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-1.01%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-1.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.21 | ||
| Fwd PE | 14.48 | ||
| P/S | 1.72 | ||
| P/FCF | 12.12 | ||
| P/OCF | 9.65 | ||
| P/B | 3.07 | ||
| P/tB | N/A | ||
| EV/EBITDA | 9.42 |
EPS(TTM)2.15
EY5.81%
EPS(NY)2.56
Fwd EY6.91%
FCF(TTM)3.05
FCFY8.25%
OCF(TTM)3.84
OCFY10.37%
SpS21.55
BVpS12.06
TBVpS-7.73
PEG (NY)1.37
PEG (5Y)2.13
Graham Number24.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.48% | ||
| ROE | 17.87% | ||
| ROCE | 11.89% | ||
| ROIC | 7.26% | ||
| ROICexc | 7.91% | ||
| ROICexgc | 21.74% | ||
| OM | 18.7% | ||
| PM (TTM) | 10% | ||
| GM | 66.57% | ||
| FCFM | 14.17% |
ROA(3y)5.95%
ROA(5y)7.95%
ROE(3y)18.55%
ROE(5y)24.89%
ROIC(3y)9.78%
ROIC(5y)10.35%
ROICexc(3y)10.97%
ROICexc(5y)11.73%
ROICexgc(3y)29.64%
ROICexgc(5y)29.05%
ROCE(3y)16.03%
ROCE(5y)16.96%
ROICexgc growth 3Y-9.69%
ROICexgc growth 5Y2.94%
ROICexc growth 3Y-20.13%
ROICexc growth 5Y-1%
OM growth 3Y-14.93%
OM growth 5Y2.07%
PM growth 3Y-24.31%
PM growth 5Y-2.64%
GM growth 3Y-0.44%
GM growth 5Y3.48%
F-Score7
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.44 | ||
| Debt/FCF | 6.15 | ||
| Debt/EBITDA | 3.09 | ||
| Cap/Depr | 49.31% | ||
| Cap/Sales | 3.63% | ||
| Interest Coverage | 4.01 | ||
| Cash Conversion | 68.3% | ||
| Profit Quality | 141.71% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 2.23 |
F-Score7
WACC6.26%
ROIC/WACC1.16
Cap/Depr(3y)41.99%
Cap/Depr(5y)70.86%
Cap/Sales(3y)3.57%
Cap/Sales(5y)4.47%
Profit Quality(3y)204.39%
Profit Quality(5y)161.92%
High Growth Momentum
Growth
EPS 1Y (TTM)28.01%
EPS 3Y-18.42%
EPS 5Y8.07%
EPS Q2Q%26.56%
EPS Next Y12.59%
EPS Next 2Y11.78%
EPS Next 3Y11.05%
EPS Next 5Y14.68%
Revenue 1Y (TTM)0.11%
Revenue growth 3Y7.79%
Revenue growth 5Y11%
Sales Q2Q%-5.36%
Revenue Next Year-0.83%
Revenue Next 2Y1.53%
Revenue Next 3Y2.28%
Revenue Next 5Y3.09%
EBIT growth 1Y5.29%
EBIT growth 3Y-8.31%
EBIT growth 5Y13.3%
EBIT Next Year57.06%
EBIT Next 3Y20.08%
EBIT Next 5Y7.73%
FCF growth 1Y-31.18%
FCF growth 3Y-4.81%
FCF growth 5Y24.67%
OCF growth 1Y-25.65%
OCF growth 3Y-7%
OCF growth 5Y14.89%
DERMAPHARM HOLDING SE / DMP.DE FAQ
What is the fundamental rating for DMP stock?
ChartMill assigns a fundamental rating of 5 / 10 to DMP.DE.
What is the valuation status for DMP stock?
ChartMill assigns a valuation rating of 5 / 10 to DERMAPHARM HOLDING SE (DMP.DE). This can be considered as Fairly Valued.
How profitable is DERMAPHARM HOLDING SE (DMP.DE) stock?
DERMAPHARM HOLDING SE (DMP.DE) has a profitability rating of 5 / 10.
Can you provide the PE and PB ratios for DMP stock?
The Price/Earnings (PE) ratio for DERMAPHARM HOLDING SE (DMP.DE) is 17.21 and the Price/Book (PB) ratio is 3.07.
What is the earnings growth outlook for DERMAPHARM HOLDING SE?
The Earnings per Share (EPS) of DERMAPHARM HOLDING SE (DMP.DE) is expected to grow by 12.59% in the next year.